Skip to content Skip to content

Press Releases


Filter Releases
 
INCLINE VILLAGE, Nev., June 5, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: (Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO) 2.875% Convertible Senior Notes due February 15, 2015 (February 2015 Notes) is 162.885 shares of common stock per $1,...
INCLINE VILLAGE, Nev., June 4, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, is scheduled to present at the Jefferies 2012 Global Healthcare Conference on Wednesday, June 6, 2012, at 4:00 p.m. ET in New York City. (Logo: http://photo...
INCLINE VILLAGE, Nev., May 8, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, is scheduled to present at the following upcoming conferences: (Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO) Eleventh Annual JMP Secu...
INCLINE VILLAGE, Nev., May 3, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the first quarter ended March 31, 2012. (Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO) Royalty revenues for the first quarter of 2012 increased five percent over the same period of 2011. Tot...
INCLINE VILLAGE, Nev., April 27, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its first quarter financial results for the period ended March 31, 2012 on Thursday, May 3, 2012 after the markets close. PDL's management will host a conference call and webcast that day at 4:30 p.m. Eastern ...
INCLINE VILLAGE, Nev., April 26, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company has appointed Bruce Tomlinson to the position of vice president and chief financial officer effective as of June 11, 2012.  Mr. Tomlinson brings more than 20 years of financial leadership experience to PDL and joins the co...
INCLINE VILLAGE, Nev., April 12, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company will hold its annual meeting of stockholders on Tuesday, June 5, 2012, at 10:00 a.m. Pacific Time for all stockholders of record on April 13, 2012. The meeting will take place at the Hyatt Regency Hotel in Incline Village,...
INCLINE VILLAGE, Nev., March 14, 2012 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the March 14, 2012, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of March 7, 2012, the record date. (Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)...
INCLINE VILLAGE, Nev., March 8, 2012 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced royalty revenue guidance for the first quarter ending March 31, 2012, of approximately $77 million, as compared with actual royalty revenue of $73 million for the first quarter of 2011, a five percent increase.  Total revenue for the first q...
INCLINE VILLAGE, Nev., March 5, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for its: 2.875% Convertible Senior Notes due February 15, 2015 (February 2015 Notes) is 159.098 shares of common stock per $1,000 principal amount or approximately $6.29 per share, effective Marc...
INCLINE VILLAGE, Nev., Feb. 23, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the fourth quarter and full year ended December 31, 2011. (Logo:  http://photos.prnewswire.com/prnh/20110822/SF55808LOGO) Total revenues in 2011 were $362 million, compared to $345 million in 2010, with royalty ...
INCLINE VILLAGE, Nev., Feb. 21, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, is scheduled to present at the following upcoming conferences: (Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO) RBC Capital Markets G...
INCLINE VILLAGE, Nev., Feb. 16, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year financial results for the period ended December 31, 2011 on Thursday, February 23, 2012 after market close. PDL's management will host a conference call and webcast that day at ...
INCLINE VILLAGE, Nev., Feb. 7, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, is scheduled to present at the 14th Annual BIO CEO & Investor Conference on Monday, February 13, 2012, at 1:00 p.m. ET in New York City. (Logo:  http://phot...
INCLINE VILLAGE, Nev., Feb. 2, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has entered into separate privately negotiated exchange agreements under which it has retired $10,028,000 aggregate principal amount of the Company's 2.875% Convertible Senior Notes due February 15, 2012 (the Old Notes). Pursuant to ...
= add release to Briefcase